FDA to speed up approvals of generic biologic medicines as Trump targets high drug costs

by | Oct 29, 2025 | Uncategorized

It’s the Trump administration’s latest move to rein in high prescription drug costs in the U.S., and could be a blow to pharmaceutical companies.

Written By

Written by Albert Pham, News Curator and Blogger

Related Posts

0 Comments